SMi Reports : Pre-Filled Syringes 2016 returns to London next January. With a selected 100+ representatives from the world's leading Pharmaceutical and Biotechnology businesses, delegates will learn the A-Z journey of PFS.
SMi Group Reports: Leading Pharma Cold Chain Distribution Experts from Genzyme, Pfizer, MHRA, World Courier, American Airlines and more will meet at the SMi Group's 10th annual Cold Chain Distribution Conference.
TP3 Global continues rapid growth and expansion with TP3 Global Americas LLC and supports the industry leading Global Cold Chain Logistics Forum this October in Boston. TP3 Global's SilverSkin range of thermal pallet covers are qualified, GDP compliant and designed for protection of cold chain and controlled room temperature shipments.
SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will cover regulatory updates, Biosimilars pharmacovigilance, patent litigation, market access, product commercialisation barriers and global market developments.
SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on the 5th - 6th October 2015 in London, will address complex market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.
SMi is delighted to announce that the 5th Annual Conference on Pharmaceutical Microbiology will be taking place on the 20th-21st January 2016 at the Holiday Inn Kensington Forum in London, UK.
SMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments.
SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on the 5th - 6th October 2015 in London, will address complex market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.
SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on the 5th - 6th October 2015 in London, will address market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.
SMi's 6th annual Biosimilars and Biobetters conference, taking place on the 30th September - 1st October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments.
SMi Group Reports : Leading pharma cold chain distribution experts will meet in London to address the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products.
SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will cover regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access, product commercialization barriers and global market developments.
SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on 5-6 October 2015 in London, will address complex market access challenges and how to overcome them with case studies from MSD, Sanofi, GSK and more.
This year's conference, taking place on 5-6 October 2015 in London, will feature an array of case studies from major global pharmaceutical companies including MSD, Sanofi and GSK.
This year's two-day conference programme will cover regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
This year's conference will address complex market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.
This year's conference will address regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access, product commercialization barriers and global market developments.
This year's conference will address the evolving biosimilar regulatory landscape, pharmacovigilance of biosimilars, patent litigation, market access, product commercialization barriers and global market developments.
This year's conference will address the latest regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
This year's conference will address regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
SMi's European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will feature an array of case studies from pharma companies including MSD, Sanofi, GSK and more.
The Peterson Group, a non-profit organization campaigning against illegal production, manufacture, distribution, importation and exportation of counterfeit drugs across the globe has been taking step by step realization of its goals and aspirations by partnering with one of the world's most renowned city to penalize anyone who is caught red handed on the use or utilization of fraudulent medicines.
This year's conference will help inform your strategic decision making so you can prepare your market access strategy for the evolving global healthcare market.
SMi's 2nd annual Immunogenicity conference, taking place on the 29th & 30th June 2015 in London, will feature an array of case studies from big pharma and biotech companies pioneering the way in cutting-edge Immunogenicity developments.
SMi's 10th annual ADMET conference will discuss the latest advancements in AMDET-enabling technologies with an array of case study driven presentations.
SMi's 6th annual Biosimilars and Biobetters conference, taking place on the 30th September - 1st October 2015 in London, will address regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and EU & global market developments.
Satisfied Users & 
Approved Press Releases
